Abstract:The hit identification stage of a drug discovery program generally involves the design of novel chemical scaffolds with desired biological activity against the target(s) of interest. One common approach is scaffold hopping, which is the manual design of novel scaffolds based on known chemical matter. One major limitation of this approach is narrow chemical space exploration, which can lead to difficulties in maintaining or improving biological activity, selectivity, and favorable property space. Another limitation is the lack of preliminary structure-activity relationship (SAR) data around these designs, which could lead to selecting suboptimal scaffolds to advance lead optimization. To address these limitations, we propose AutoDesigner - Core Design (CoreDesign), a de novo scaffold design algorithm. Our approach is a cloud-integrated, de novo design algorithm for systematically exploring and refining chemical scaffolds against biological targets of interest. The algorithm designs, evaluates, and optimizes a vast range - from millions to billions - of molecules in silico, following defined project parameters encompassing structural novelty, physicochemical attributes, potency, and selectivity. In this manner, CoreDesign can generate novel scaffolds and also explore preliminary SAR around each scaffold using FEP+ potency predictions. CoreDesign requires only a single ligand with quantifiable binding affinity and an initial binding hypothesis, making it especially suited for the hit-identification stage where experimental data is often limited. To validate CoreDesign in a real-world drug discovery setting, we applied it to the design of novel, potent Wee1 inhibitors with improved selectivity over PLK1. Starting from a single known ligand, CoreDesign rapidly explored over 23 billion molecules to identify 1,342 novel chemical series with a mean of 4 compounds per scaffold. Importantly, all chemical series met the predefined property space requirements. To rapidly analyze this large amount of data and prioritize chemical scaffolds for synthesis, we utilize t-Distributed Stochastic Neighbor Embedding (t-SNE) plots of in silico properties. The chemical space projections allowed us to rapidly identify a structurally novel 5-5 fused core meeting all the hit-identification requirements. Several compounds were synthesized and assayed from the scaffold, displaying good potency against Wee1 and excellent PLK1 selectivity. Our results suggest that CoreDesign can significantly speed up the hit-identification process and increase the probability of success of drug discovery campaigns by allowing teams to bring forward high-quality chemical scaffolds de-risked by the availability of preliminary SAR.

Pocket Crafter: a 3D generative modeling based workflow for the rapid generation of hit molecules in drug discovery

3D Molecular Generation via Virtual Dynamics

Pocket2Mol: Efficient Molecular Sampling Based on 3D Protein Pockets.

PocketFlow is a data-and-knowledge-driven structure-based molecular generative model

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

A pocket-based 3D molecule generative model fueled by experimental electron density

Learning Subpocket Prototypes for Generalizable Structure-based Drug Design

In-Pocket 3D Graphs Enhance Ligand-Target Compatibility in Generative Small-Molecule Creation

3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds

Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design

Generation of 3D molecules in pockets via a language model

SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design

3D molecular generative framework for interaction-guided drug design

Functional-Group-Based Diffusion for Pocket-Specific Molecule Generation and Elaboration

PILOT: equivariant diffusion for pocket-conditioned de novo ligand generation with multi-objective guidance via importance sampling

Accelerating Discovery of Novel and Bioactive Ligands With Pharmacophore-Informed Generative Models

AutoDesigner - Core Design, a De Novo Design Algorithm for Chemical Scaffolds: Application to the Design and Synthesis of Novel Selective Wee1 Inhibitors

Generation of 3D Molecules in Pockets via Language Model

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

Structure-based <i>de novo</i> drug design using 3D deep generative models

3D Molecular Pocket-based Generation with Token-only Large Language Model